ThinkSabio

$CMND

$6.50▲ -1.4% YTD

11 SEC 13D/G filings tracked · Last updated Oct 12, 2026

Filing History
News
CMND ▼ -1.4% - Clearmind Medicine Inc.
CP $6.50▲ -1.4%Oct 12, 2026 · ThinkSabio Blog

$CMND - Clearmind: Charging Robotics Launches Next-Generation Automated EV-Charging Technology for Robotaxis and Autonomous Fleets…

News
CMND ▼ -0.9% - Clearmind Medicine Inc.
CP $6.54▲ -0.9%Oct 8, 2026 · ThinkSabio Blog

$CMND - Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder…

News
CMND ▼ -11.1% - Clearmind Medicine Inc.
CP $5.20▲ -11.1%Oct 7, 2026 · ThinkSabio Blog

$CMND - Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA…

News
CMND ▼ -11.1% - Clearmind Medicine Inc.
CP $5.20▲ -11.1%Oct 7, 2026 · ThinkSabio Blog

$CMND - Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA…

News
CMND ▲ +2.5% - Clearmind Medicine Inc.
CP $0.83▲ +2.5%Sep 17, 2026 · ThinkSabio Blog

$CMND - Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C…

News
CMND ▲ +5.1% - Clearmind Medicine Inc.
CP $1.03▲ +5.1%Sep 11, 2026 · ThinkSabio Blog

$CMND - Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial…

News
CMND ▼ -14.7% - Clearmind Medicine Inc.
CP $0.99▲ -14.7%Sep 8, 2026 · ThinkSabio Blog

$CMND vol pop…

News
CMND ▼ -3.4% - Clearmind Medicine Inc.
CP $1.12▲ -3.4%Sep 8, 2026 · ThinkSabio Blog

$CMND - Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive…

News
CMND ▲ +19.9% - Clearmind Medicine Inc.
CP $2.05▲ +19.9%Sep 4, 2026 · ThinkSabio Blog

$CMND - Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis…

News
CMND ▼ -2.6% - Clearmind Medicine Inc.
CP $1.87▲ -2.6%Sep 1, 2026 · ThinkSabio Blog

$CMND - Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled…

SEC 13D/G
CMND - Clearmind Medicine Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks Simplified
$1.65▼ -91.71%Aug 12, 2026 · ThinkSabio Blog

$CMND SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CMND Clearmind Medicine Inc. : $1.65 Sector: Healthcare | YTD:…